HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusuke Kabeya Selected Research

Paranasal Sinus Diseases

5/2016Higher Body Mass Index and Increased Prevalence of Paranasal Sinus Disease.
1/2015Association between diabetes and increased prevalence of paranasal sinus disease: a cross-sectional study in Japanese adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusuke Kabeya Research Topics

Disease

4Acute Coronary Syndrome
01/2022 - 02/2016
4Type 2 Diabetes Mellitus (MODY)
10/2019 - 01/2011
2Paranasal Sinus Diseases
05/2016 - 01/2015
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Neoplasms (Cancer)
01/2020
1Diabetes Mellitus
01/2020
1Hypertension (High Blood Pressure)
11/2019
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2018
1Cardiac Arrhythmias (Arrythmia)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2017
1Dyspnea (Shortness of Breath)
12/2016
1Pneumonia (Pneumonitis)
12/2016
1Colonic Neoplasms (Colon Cancer)
01/2015
1Ventricular Tachycardia
01/2014
1Insulin Resistance
01/2012
1Kidney Calculi (Kidney Stone)
01/2012

Drug/Important Bio-Agent (IBA)

3Hemoglobins (Hemoglobin)IBA
05/2016 - 01/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2019 - 01/2019
2Insulin (Novolin)FDA Link
04/2017 - 01/2012
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2017 - 01/2012
1PotassiumIBA
01/2020
1CreatinineIBA
11/2019
1Pharmaceutical PreparationsIBA
10/2019
1BilirubinIBA
01/2018
1AntioxidantsIBA
01/2018
1Hypnotics and Sedatives (Sedatives)IBA
04/2017
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2017
1ORALIT (ORS)IBA
01/2015
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2012
1Pioglitazone (Actos)FDA Link
01/2011

Therapy/Procedure

4Percutaneous Coronary Intervention
01/2022 - 02/2016
1Polypharmacy
10/2019
1Perioperative Period
01/2018
1Injections
04/2017
1Artificial Respiration (Mechanical Ventilation)
12/2016
1Length of Stay
12/2016
1Renal Replacement Therapy (Therapies, Renal Replacement)
12/2016
1Activities of Daily Living (ADL)
02/2016
1Rewarming
01/2014
1Glycemic Control
01/2012